{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:40:18Z","timestamp":1790872818908,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T00:00:00Z","timestamp":1291766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00431-010-1366-5","type":"journal-article","created":{"date-parts":[[2010,12,7]],"date-time":"2010-12-07T06:40:08Z","timestamp":1291704008000},"page":"873-877","source":"Crossref","is-referenced-by-count":15,"title":["Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B12, folate levels, and lipid profiles in epileptic children treated with valproic acid"],"prefix":"10.1007","volume":"170","author":[{"given":"Ozlem","family":"Ozdemir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayten","family":"Yakut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ener Cagri","family":"Dinleyici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan Durmus","family":"Aydogdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coskun","family":"Yarar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Colak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,8]]},"reference":[{"key":"1366_CR1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-1211(02)00153-5","volume":"51","author":"T Apeland","year":"2002","unstructured":"Apeland T, Mansoor MA, Pentieva K et al (2002) The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs. Epilepsy Res 51:237\u2013247","journal-title":"Epilepsy Res"},{"key":"1366_CR2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.pnpbp.2003.11.019","volume":"28","author":"S Bleich","year":"2004","unstructured":"Bleich S, Degner D, Sperling W et al (2004) Homocysteine as a neurotoxin in chronic alcoholism. Prog Neuropsychopharmacol Biol Psychiatry 28:453\u2013464","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1366_CR3","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","volume":"98","author":"RH B\u00f6ger","year":"1998","unstructured":"B\u00f6ger RH, Bode-B\u00f6ger SM, Szuba A et al (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98:1842\u20131847","journal-title":"Circulation"},{"key":"1366_CR4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/08830738060210011601","volume":"21","author":"M Castro-Gago","year":"2006","unstructured":"Castro-Gago M, Novo-Rodr\u00edguez MI, Blanco-Barca MO et al (2006) Evolution of serum lipids and lipoprotein (a) levels in epileptic children treated with carbamazepine, valproic acid, and phenobarbital. J Child Neurol 21:48\u201353","journal-title":"J Child Neurol"},{"key":"1366_CR5","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","volume":"324","author":"R Clarke","year":"1991","unstructured":"Clarke R, Daly L, Robinson K et al (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149\u20131155","journal-title":"N Engl J Med"},{"key":"1366_CR6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/tropej\/fmk001","volume":"52","author":"EC Dinleyici","year":"2006","unstructured":"Dinleyici EC, Kirel B, Alatas O et al (2006) Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors. J Trop Pediatr 52:260\u2013266","journal-title":"J Trop Pediatr"},{"key":"1366_CR7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1528-1157.1992.tb02203.x","volume":"33","author":"E Franzoni","year":"1992","unstructured":"Franzoni E, Govoni M, D'Addato S et al (1992) Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepileptic drugs. Epilepsia 33:932\u2013935","journal-title":"Epilepsia"},{"key":"1366_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eplepsyres.2005.03.005","volume":"64","author":"BE Gidal","year":"2005","unstructured":"Gidal BE, Tamura T, Hammer A, Vuong A (2005) Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy. Epilepsy Res 64:161\u2013166","journal-title":"Epilepsy Res"},{"key":"1366_CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00148581-200608020-00004","volume":"8","author":"R Guerrini","year":"2006","unstructured":"Guerrini R (2006) Valproate as a mainstay of therapy for pediatric epilepsy. Paediatr Drugs 8:113\u2013129","journal-title":"Paediatr Drugs"},{"key":"1366_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0387-7604(02)00163-8","volume":"25","author":"H Karabiber","year":"2003","unstructured":"Karabiber H, Sonmezgoz E, Ozerol E et al (2003) Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12 and folic acid. Brain Dev 25:113\u2013115","journal-title":"Brain Dev"},{"key":"1366_CR11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1742-7843.2006.pto_402.x","volume":"98","author":"GA Karikas","year":"2006","unstructured":"Karikas GA, Schulpis KH, Bartzeliotou A et al (2006) Lipids, lipoproteins, apolipoproteins, selected trace elements and minerals in the serum of children on valproic acid monotherapy. Basic Clin Pharmacol Toxicol 98:599\u2013603","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1366_CR12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1681\/ASN.V103594","volume":"10","author":"JT Kielstein","year":"1999","unstructured":"Kielstein JT, B\u00f6ger RH, Bode-B\u00f6ger SM et al (1999) Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10:594\u2013600","journal-title":"J Am Soc Nephrol"},{"key":"1366_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1567-5688(03)00035-7","volume":"4","author":"SR Lentz","year":"2003","unstructured":"Lentz SR, Rodinov NR, Sanjana D (2003) Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the poteintial role of ADMA. Atheroscler 4:61\u201365","journal-title":"Atheroscler"},{"key":"1366_CR14","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1073\/pnas.94.11.5923","volume":"94","author":"SA Lipton","year":"1997","unstructured":"Lipton SA, Kim WK, Choi YB et al (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 94:5923\u20135928","journal-title":"Proc Natl Acad Sci USA"},{"key":"1366_CR15","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.CIR.87.4.1107","volume":"87","author":"MR Malinow","year":"1993","unstructured":"Malinow MR, Nieto FJ, Szklo M et al (1993) Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation 87:1107\u20131113","journal-title":"Circulation"},{"key":"1366_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1528-1157.1990.tb05371.x","volume":"31","author":"PJ Marangos","year":"1990","unstructured":"Marangos PJ, Loftus T, Wiesner J et al (1990) Adenosinergic modulation of homocysteine-induced seizures in mice. Epilepsia 31:239\u2013246","journal-title":"Epilepsia"},{"key":"1366_CR17","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.274.19.1526","volume":"274","author":"O Nyg\u00e5rd","year":"1995","unstructured":"Nyg\u00e5rd O, Vollset SE, Refsum H et al (1995) Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274:1526\u20131533","journal-title":"JAMA"},{"key":"1366_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0387-7604(02)00004-9","volume":"24","author":"H Ono","year":"2002","unstructured":"Ono H, Sakamoto A, Mizoguchi N, Sakura N (2002) The C677T mutation in the methylenetetrahydrofolate reductase gene contributes to hyperhomocysteinemia in patients taking anticonvulsants. Brain Dev 24:223\u2013226","journal-title":"Brain Dev"},{"key":"1366_CR19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.eplepsyres.2009.07.011","volume":"87","author":"O Oz","year":"2009","unstructured":"Oz O, G\u00f6k\u00e7il Z, Bek S et al (2009) Is asymmetric dimethylarginine responsible for the vascular events in patients under antiepileptic drug treatment? Epilepsy Res 87:54\u201358","journal-title":"Epilepsy Res"},{"key":"1366_CR20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3181\/00379727-180-42189","volume":"180","author":"MN Reddy","year":"1985","unstructured":"Reddy MN (1985) Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol and apolipoproteins A and B in children with epilepsy. Proc Soc Exp Biol Med 180:359\u2013363","journal-title":"Proc Soc Exp Biol Med"},{"key":"1366_CR21","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1161\/01.CIR.92.10.2825","volume":"92","author":"K Robinson","year":"1995","unstructured":"Robinson K, Mayer EL, Miller DP et al (1995) Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 92:2825\u20132830","journal-title":"Circulation"},{"key":"1366_CR22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.seizure.2005.11.002","volume":"15","author":"U Sener","year":"2006","unstructured":"Sener U, Zorlu Y, Karaguzel O et al (2006) Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6. Seizure 15:79\u201385","journal-title":"Seizure"},{"key":"1366_CR23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s004310050664","volume":"156","author":"DT Sozuer","year":"1997","unstructured":"Sozuer DT, Atakl\u0131 D, Do\u011fu O et al (1997) Serum lipids in epileptic children treated with carbamazepine and valproate. Eur J Pediatr 156:565\u2013567","journal-title":"Eur J Pediatr"},{"key":"1366_CR24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005344-199904000-00020","volume":"33","author":"A Surdacki","year":"1999","unstructured":"Surdacki A, Nowicki M, Sandmann J (1999) Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetrical dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 33:652\u2013658","journal-title":"J Cardiovasc Pharmacol"},{"key":"1366_CR25","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/S0024-3205(98)00225-2","volume":"62","author":"M Usui","year":"1998","unstructured":"Usui M, Matsuoka H, Miyazaki H et al (1998) Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci 62:2425\u20132430","journal-title":"Life Sci"},{"key":"1366_CR26","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","volume":"358","author":"VP Valkonen","year":"2001","unstructured":"Valkonen VP, P\u00e4iv\u00e4 H, Salonen JT et al (2001) Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358:2127\u20132128","journal-title":"Lancet"},{"key":"1366_CR27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.ATV.0000128897.54893.26","volume":"24","author":"P Vallance","year":"2004","unstructured":"Vallance P, Leiper J (2004) Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24:1023\u20131030","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1366_CR28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/ejpn.2000.0379","volume":"4","author":"MA Vilaseca","year":"2000","unstructured":"Vilaseca MA, Monr\u00f3s E, Artuch R et al (2000) Anti-epileptic drug treatment in children: hyperhomocysteinaemia, B-vitamins and the 677C\u2013>T mutation of the methylenetetrahydrofolate reductase gene. Eur J Paediatr Neurol 4:269\u2013277","journal-title":"Eur J Paediatr Neurol"},{"key":"1366_CR29","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","volume":"358","author":"C Zoccali","year":"2001","unstructured":"Zoccali C, Bode-B\u00f6ger S, Mallamaci F et al (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358:2113\u20132117","journal-title":"Lancet"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1366-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-010-1366-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1366-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T19:50:00Z","timestamp":1636919400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-010-1366-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,8]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1366"],"URL":"https:\/\/doi.org\/10.1007\/s00431-010-1366-5","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,8]]}}}